TOP2A and malignant peripheral nerve sheath tumor: Gene expression profiles serve to identify disease biomarkers, such as BIRC5, TOP2A and TK1, that categorize MPNST patients with poor prognosis after surgery [10], or might also help to identify new therapeutic agents through drug repositioning, i. e., use of tested drugs to treat new disease indications [19].